St. John’s (Newfoundland), October 25, 2011 – Semintha Nutraceutical Ltd. (“Semintha”) is pleased to announced that Dr. Pavel A. Krasutsky, Director of Chemical Extractives Program at the Natural Resources Research Institute, University of Minnesota is joining Semintha’s Scientific Advisory Board.
Dr. Krasutsky is one of the world’s leading experts on extractive technologies, analyses and applications relative to birch bark. He holds over 33 patents resulting from his research on extraction technologies and producing bioactive substances from birch trees and other natural products. “I am delighted to be invited to join the Scientific Advisory Board and I look forward to working with the management and scientific team of Semintha toward the commercialization of added-value health-products formulated from extracted bioactive molecules from the birch tree components”, mentioned Dr. Krasutsky.
Semintha’s Chief Science Officer and Vice-President of Research and Development (R&D), Scientific and Regulatory Affairs, Dr Bruno Battistini said that “Dr. Krasutsky’s contribution to Semintha’s Scientific Advisory Board is highly valuable and represents the first building block to further advance the research and development efforts pushing toward rapid validation and commercialization of added-value health products derived from birch trees”. Nicholas P. Katsepontes, President and CEO, added that “Semintha is one of the first companies in the world to recognize and pursue an agenda of researching, formulating, clinically testing and regulatory approvals of such health products derived from birch trees and because of this approach, Semintha will emerge as the global leader”.
Located in Central Newfoundland, Semintha currently has a number of products under development in the cosmeceutical and nutraceutical areas that will be entering clinical validation in early 2012. Semintha is affiliated with Central Newfoundland Birch Products Inc. (CNBPI) which has acquired harvesting rights. Semintha’s goal is to become a world leader in nutraceutical, cosmeceutical and pharmaceutical products containing birch tree extracts, and other bioactives from natural biomasses of the Boreal Forest, inviting major functional food, cosmetic, nutraceutical and pharma companies as its customers.
Dr. Krasutsky will be in St. Johns’ NL on Wednesday, October 26 to present at the NATI Bio-Partnering Event www.nati.net/events-and-programs/events-calendar/bio-partnering-forum.aspx and is available for media interviews from 12-2pm at the Bella Vista, on 26 Torbay Road.
About NRRI The Natural Resources Research Institute (www.nrri.umn.edu) has developed a chemical extractives laboratory that measure valuable natural chemicals within natural resources that hold potential for medicines, cosmetics, nutraceuticals, plant protection and other uses. The CASEO Center (www.nrri.umn.edu/cartd/lce/CASEO.htm) provides services to industrial partners from Minnesota, U.S., Canada, and Europe in Chemistry, Analytics, Synthesis, Engineering and Optimization. Experienced lab employees and unique equipment (including pilot scale apparatus) are available to resolve complicated tasks for pharmaceutical, cosmeceutical, nutraceutical, agrichemical, chemical and other industries. The Chemical Extractives Lab can analyze and optimize technologies, selectively modify chemical structures, and provide companies with large samples.
About CNBPI Central NL Birch Products Inc. (www.birchharvest.com) was incorporated in Canada in June 2010. By August 2010, the company was subsequently registered in the Province of Newfoundland and Labrador. Newfoundland was chosen due to its government support and vast land resources of birch trees. In 2011, CNBPI applied for several provincial and regional grants and matching loans and started to receive such support. The company has also secured large portions of land in Central Newfoundland for 15 years with an option to renew. The land contains approximately 60,000 birch trees representing approximately a 3 million liter sap reserve. Additional land applications have been recently submitted to the Province of Newfoundland that will secure over 1,500 hundred acres, representing approximately 300,000 harvestable trees.
About Semintha Semintha Nutraceuticals Ltd (www.seminthanutraceuticals.com) was incorporated in Canada in December 2010 and is registered to do business in the Province of Newfoundland and Quebec whose specific mandate is to provide scientific and regulatory guidance for CNBPI transformation and extraction of birch tree raw materials and to further formulate and validate medical claims, and commercialize added-value functional beverages, nutraceutical, cosmeceutical and pharmaceutical products. Presently, Semintha has developed its first line of products – cosmeceutical soap bars – toward alleviating skin disorders. Semintha, through a predetermined and planned R&D pathway, will create additional extracts as products that can be formulated into a variety of nutricosmetics, cosmeceuticals and nutraceuticals.